Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.

Lili ChenYanyang ChenZhongpeng XieJiao LuoYuefeng WangJianwen ZhouLeilei HuangHongxia LiLinhai WangPei LiuMan ShuWenhui ZhangZun-Fu Ke

Published in: Breast cancer research and treatment (2022)

Evaluation of breast cancer biomarker status by RT-qPCR was highly concordant with IHC. RT-qPCR can be used as a supplementary method to detect molecular markers of breast cancer.

Keyphrases

neoadjuvant chemotherapy
estrogen receptor
squamous cell carcinoma
endoplasmic reticulum